← Evidence map

ArticleDrug safety2008

Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors.

Espen Molden et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 18558792